Trivarx (ASX: TRI) (OTCQB:MDBIF) is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx’s clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart-rate variability. The company was founded in Australia, with offices located in Perth (WA) and U.S. offices in Minneapolis, MN.